FDA Requests Removal of All Zantac Products From Stores
New FDA data is prompting the agency to request removal of all Zantac and other ranitidine products from stores. This product is contaminated with N-Nitrosodimethylamine (NDMA), which is a probable human carcinogen. Public health officials have found that the impurity in some ranitidine products increases over time, especially when the drug is stored at higher … Read more